Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01746277 | Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00173888 | Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 |
| clinicaltrials |
| NCT01742767 | Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC(PemSplitCisp) | unknown | Phase 2 | — | Universität Duisburg-EssenOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT01004510 | Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer(ZAP) | terminated | Phase 2 | 3 | Peter Bushunow MDOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00482014 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer | completed | Phase 1 / Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 27, 2012 | clinicaltrials |
| NCT00695994 | The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients | completed | Phase 2 | 300 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00682383 | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 26 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00840125 | Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment | completed | Phase 2 | 4 | Meir Medical CenterOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT01218594 | Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer(DP-EN-RT) | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT01688713 | Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer | unknown | Phase 2 | 20 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT01687439 | Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | Fudan UniversityOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00991796 | CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 109 | Daiichi SankyoINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00694603 | Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy | terminated | Phase 2 | 56 | Lecia V. SequistOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00988936 | Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug(K5-101) | completed | Phase 2 | 35 | Siemens Molecular ImagingINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00093132 | Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy | terminated | Phase 1 / Phase 2 | 20 | AgennixINDUSTRY | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00085839 | Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 | completed | Phase 2 | 103 | OSI PharmaceuticalsINDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00294762 | Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC | completed | Phase 2 | 143 | OSI PharmaceuticalsINDUSTRY | 2 | Aug 9, 2012 | clinicaltrials |
| NCT00386555 | A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. | withdrawn | Phase 2 | 0 | Arog Pharmaceuticals, Inc.INDUSTRY | 0 | Aug 9, 2012 | clinicaltrials |
| NCT00680940 | A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 221 | Cadila PharnmaceuticalsINDUSTRY | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00048087 | Iressa/Docetaxel in Non-Small-Cell Lung Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors(DIPROCOL) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00401492 | MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 159 | National Cancer Institute, NaplesOTHER | 0 | Jul 13, 2012 | clinicaltrials |
| NCT01481259 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
| NCT00522938 | Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 2 | Chroma TherapeuticsINDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT01574729 | Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma(rAd-p53) | unknown | Phase 2 | 120 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00094094 | Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT01502202 | Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers | unknown | Phase 2 | 162 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00887549 | A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 19, 2012 | clinicaltrials |
| NCT00367679 | Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 3 | Jun 12, 2012 | clinicaltrials |
| NCT00312975 | Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 90 | AstraZenecaINDUSTRY | 5 | Jun 7, 2012 | clinicaltrials |
| NCT00745875 | ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 5 | Jun 6, 2012 | clinicaltrials |
| NCT00088556 | Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 100 | TelikINDUSTRY | 1 | May 31, 2012 | clinicaltrials |
| NCT00330746 | CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer(CALC-1) | completed | Phase 2 | 100 | National Cancer Institute, NaplesOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00251446 | A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00251524 | A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC | completed | Phase 2 | 69 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00098254 | BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00291850 | Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC | terminated | Phase 2 | 50 | Central European Cooperative Oncology GroupOTHER | 3 | May 1, 2012 | clinicaltrials |
| NCT00268970 | Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 30, 2012 | clinicaltrials |
| NCT01581346 | Exercise Study in Patients With Lung Cancer(POSITIVE) | completed | Phase 2 | 40 | German Cancer Research CenterOTHER | 1 | Apr 20, 2012 | clinicaltrials |
| NCT00652340 | APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer(TP2001-201) | completed | Phase 2 | 120 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 9, 2012 | clinicaltrials |
| NCT00442754 | Dendritic Cells in Lung Cancer | completed | Phase 2 | 50 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00517595 | Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC | completed | Phase 2 | 48 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00816868 | A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung | completed | Phase 2 | 62 | Sun Yat-sen UniversityOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT00034957 | Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | PfizerINDUSTRY | 1 | Feb 16, 2012 | clinicaltrials |
| NCT01270386 | A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | completed | Phase 2 | 136 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 10, 2012 | clinicaltrials |
| NCT01527864 | Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer | unknown | Phase 2 | 300 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00138658 | A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 85 | Achieve Life SciencesINDUSTRY | 2 | Feb 6, 2012 | clinicaltrials |
| NCT00408226 | Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01083589 | Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Dec 10, 2012source: clinicaltrials